ASHLEY CHRISTIAN: Open Payments
NPI 1073070702 · POPLAR BLUFF, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 90 payments from 13 companies in 2025. Trend: 2023 $495 · 2024 $887 · 2025 $1,666
Food & beverage: $1,658Education: $8
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 16 | $296 |
| Alkermes, Inc. | 17 | $272 |
| Neurocrine BioSciences, Inc. | 12 | $231 |
| Teva Pharmaceuticals USA, Inc. | 12 | $205 |
| Lundbeck LLC | 7 | $156 |
| E.R. Squibb & Sons, L.L.C. | 7 | $143 |
| Janssen Pharmaceuticals, Inc | 6 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $83 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
Products named: REXULTI, ARISTADA, INGREZZA, UZEDY, ABILIFY MAINTENA, COBENFY, CAPLYTA, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
